Prevalence and Predictors of Polypharmacy, Self-medication, and Poor Medication Adherence among Hypertensive Patients of Bangladesh

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background Hypertension, a highly prevalent yet preventable risk factor for numerous diseases, affects approximately 1.28 billion adults globally, with a disproportionate burden in low- and middle-income countries such as Bangladesh. This study aims to assess the prevalence and determinants of polypharmacy, self-medication, and medication adherence among adults with hypertension to improve treatment outcomes and enhance patients’ quality of life. Materials and Methods A total of 496 adult hypertensive patients on anti-hypertensives were recruited using convenience sampling from ten government hospital outpatient clinics and ten private physicians’ offices throughout Bangladesh participated in this cross-sectional study. Data were collected by face-to-face interview using a semi-structured questionnaire containing demographic questions, the Medication Adherence Report Scale (MARS-5), a self-medication evaluation tool, and a comprehensive medication history record. Collected data were analyzed using Stata (version 17). Results The mean age of the participants were 54.26 ± 11.90, with 54.04% (273) being male. Self-medication, poor adherence, and polypharmacy were observed in 88.9%, 55.9%, and 20.0% of the participants, respectively. Poor adherence was associated with self-medication (AOR 0.27; 95% CI 0.14–0.53) and disability (AOR 0.38; 95% CI 0.19–0.78), and was improved by satisfaction with healthcare (AOR 2.27; 95% CI 1.16–4.44) and family history of chronic disease (AOR 1.78; 95% CI 1.18–2.68). Self-medication was more likely among those dissatisfied with medicines (AOR 5.06; 95% CI 1.57–16.33) and facing financial difficulty (AOR 2.06; 95% CI 1.02–4.13). Polypharmacy increased with age (AOR 1.04; 95% CI 1.01–1.07), sub-urban (AOR 2.87; 95% CI 1.16–7.10) and urban residence (AOR 2.65; 95% CI 1.21–5.84), multimorbidity, and family history (AOR 1.90; 95% CI 1.12–3.23). Conclusion

Article activity feed